Spyre Therapeutics, Inc. (SYRE) Earnings
NASDAQ·Healthcare·Biotechnology
$99.88
+5.40%
Mkt Cap $8.50B
EPS — Estimate vs Actual
Mkt Cap
$8.50B
P/E
—
Fwd P/E
—
P/S
93.92
Rev TTM
—
EPS TTM
-$2.19
NASDAQ·Healthcare·Biotechnology
$99.88
+5.40%
Mkt Cap $8.50B
Mkt Cap
$8.50B
P/E
—
Fwd P/E
—
P/S
93.92
Rev TTM
—
EPS TTM
-$2.19